Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongqiang Guo

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Annals of Hematology|January 8, 2025
A prognostic index for advanced-stage extranodal natural killer/T-cell lymphoma: A multicenter studyXiaojie Fang, Fenglan Zhou, Sheng Ye, et al.
Molecular Immunology|December 30, 2016
Cathepsin S inhibition changes regulatory T-cell activity in regulating bladder cancer and immune cell proliferation and apoptosisXiang Yan, Chun Wu, Tao Chen, et al.
Cancer Medicine|November 24, 2023
Primary breast diffuse large B-cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology GroupHuawei Weng, Prem Raj Shrestha, Huangming Hong, et al.
Blood Advances|March 13, 2026
Dynamic monitoring of circulating cell-free EBV-DNA for risk assessment in early-stage natural killer/T-cell lymphomaZegeng Chen, He Huang, Xiaojie Fang, et al.
American Journal of Hematology|January 29, 2019
A prognostic index for nasal-type early-stage extranodal natural killer/T-cell lymphoma: A multicenter studyHuangming Hong, He Huang, Xiaojie Fang, et al.
Cancer Medicine|April 30, 2022
A novel prognostic nomogram for patients with extragastric mucosa-associated lymphoid tissue lymphoma: A multicenter studyXiaoqian Li, Huangming Hong, He Huang, et al.
Annals of Hematology|March 3, 2026
An inflammation-integrated prognostic nomogram for advanced-stage extranodal NK/T-cell lymphoma: a multicenter retrospective studyYongle Xia, Yinjie Zhang, Renqin Li, et al.
Journal of Hematology & Oncology|April 27, 2025
A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphomaHuangming Hong, Zegeng Chen, Mingzhi Zhang, et al.
Leukemia|February 20, 2024
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphomaZegeng Chen, He Huang, Huageng Huang, et al.
Biomarker Research|January 24, 2023
The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognosesYungchang Chen, Hao Sun, Yanhong Deng, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Annals of Hematology|January 8, 2025
A prognostic index for advanced-stage extranodal natural killer/T-cell lymphoma: A multicenter studyXiaojie Fang, Fenglan Zhou, Sheng Ye, et al.
Molecular Immunology|December 30, 2016
Cathepsin S inhibition changes regulatory T-cell activity in regulating bladder cancer and immune cell proliferation and apoptosisXiang Yan, Chun Wu, Tao Chen, et al.
Cancer Medicine|November 24, 2023
Primary breast diffuse large B-cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology GroupHuawei Weng, Prem Raj Shrestha, Huangming Hong, et al.
Blood Advances|March 13, 2026
Dynamic monitoring of circulating cell-free EBV-DNA for risk assessment in early-stage natural killer/T-cell lymphomaZegeng Chen, He Huang, Xiaojie Fang, et al.
American Journal of Hematology|January 29, 2019
A prognostic index for nasal-type early-stage extranodal natural killer/T-cell lymphoma: A multicenter studyHuangming Hong, He Huang, Xiaojie Fang, et al.
Cancer Medicine|April 30, 2022
A novel prognostic nomogram for patients with extragastric mucosa-associated lymphoid tissue lymphoma: A multicenter studyXiaoqian Li, Huangming Hong, He Huang, et al.
Annals of Hematology|March 3, 2026
An inflammation-integrated prognostic nomogram for advanced-stage extranodal NK/T-cell lymphoma: a multicenter retrospective studyYongle Xia, Yinjie Zhang, Renqin Li, et al.
Journal of Hematology & Oncology|April 27, 2025
A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphomaHuangming Hong, Zegeng Chen, Mingzhi Zhang, et al.
Leukemia|February 20, 2024
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphomaZegeng Chen, He Huang, Huageng Huang, et al.
Biomarker Research|January 24, 2023
The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognosesYungchang Chen, Hao Sun, Yanhong Deng, et al.
Pageof 5